- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06839040
Effects of a Multidisciplinary Intervention on Fall Risk and Urinary Incontinence in Older Women (FIRE-WOMEN)
This will be a quantitative, quasi-experimental, and longitudinal study spanning 18 weeks of intervention, followed by a 24-week follow-up, scheduled to begin in January 2025.
The primary objective of this study is to evaluate the effects of a multidisciplinary intervention comprising physiotherapy, physical exercise, and psychoeducation on fall risk and urinary incontinence in non-institutionalized older adult women aged 60 to 80 years. Participants will be randomly assigned to one of four groups:
- A multicomponent exercise group with verbal instructions for pelvic floor exercises.
- A multicomponent exercise group with verbal instructions for pelvic floor exercises and psychoeducation.
- A multicomponent exercise group without verbal instructions for pelvic floor exercises.
- A control group.
Multicomponent exercise sessions will be conducted twice a week, while the psychoeducation group will participate in five group therapy sessions throughout the program. The variables to be analyzed include balance, strength, power, pelvic floor function, quality of life, and self-esteem.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The aging process can lead to the development of major geriatric syndromes, such as falls and urinary incontinence. Although there are studies demonstrating the effectiveness of physical exercise and education in addressing these conditions, there is currently very limited evidence on the combined effects of both therapies on these syndromes.
The primary objective of this study is to evaluate the effects of a multidisciplinary intervention consisting of physiotherapy, physical exercise, and psychoeducation on the risk of falls and urinary incontinence in older adult women.
Methods: This will be a quantitative, quasi-experimental, and longitudinal study with 18 weeks of intervention and a 24-week follow-up period. The study is scheduled to begin in January 2025. The sample will consist of non-institutionalized older adult women aged between 60 and 80 years, who will be randomly assigned to one of four groups:
- A multicomponent exercise group with verbal instructions targeting the pelvic floor.
- A multicomponent exercise group with verbal instructions targeting the pelvic floor and psychoeducation.
- A multicomponent exercise group without verbal instructions targeting the pelvic floor.
- A control group.
Multicomponent exercise sessions will be conducted twice a week and will include exercises focused on balance, strength/power using elastic bands, aerobic capacity, and coordination. The verbal instructions for the pelvic floor will involve performing fast and slow contractions during the general exercises. Participants in the psychoeducation group will attend five group therapy sessions throughout the program.
The study will analyze variables related to balance (Timed Up and Go test, functional reach test, and posturography), lower limb strength/power (isometric strength tests and jump performance), and pelvic floor function (using the PERFECT scale and electromyography). Additionally, physical, psychological, and social well-being variables will be assessed using instruments such as the SF-36, ICIQ-SF, and Rosenberg self-esteem scale.
Results/Conclusion: It is anticipated that differences will emerge between the study groups, with the trimodal intervention group (multicomponent exercise + specific verbal instructions for the pelvic floor + psychoeducation) showing greater improvements in certain parameters.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: ESTHER RAMOS CASTELLANO
- Phone Number: +34672425826
- Email: esther.ramos@ucv.es
Study Locations
-
-
-
Valencia, Spain, 46001
- Recruiting
- Escuela de Doctorado. Universidad Católica de Valencia San Vicente Mártir. (Doctoral School. Catholic University of ValenciaSan Vicente Mártir)
-
Contact:
- ESTHER RAMOS CASTELLANO
- Phone Number: +34672425826
- Email: esther.ramos@ucv.es
-
Contact:
- Pedro Gargallo Bayo, Full professor
- Email: pedro.gargallo@uv.es
-
Contact:
- ESTHER RAMOS CASTELLANO
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Woman, aged between 60 and 80 years.
- Not having done physical exercise in the last 3 months.
- Present UI (SUI, UUI or MUI) after clinical diagnosis.
- Score greater than 90 on the Barthel Scale.
- Not present pathologies or functional alterations that limit the practice of physical exercise.
- Not present severe cognitive alterations or mild cognitive deficit (Global Deterioration Scale less than or equal to 2 or Mini Mental State Examination greater than or equal to 25 points).
- Maintain walking without support products.
- Carry out 80% of the total sessions
Exclusion Criteria:
- Intake of medication that could affect the performance of the exercise or alter the variables studied.
- Present grade II-IV uterine prolapses.
- Clinical disease or syndrome (chronic or acute cardiovascular, neurological, respiratory or musculoskeletal disorders) that may interfere with the performance of the intervention and evaluation.
- Present visual and/or auditory alterations that make it difficult to carry out the intervention and evaluation.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Multi-component exercise group with verbal instructions for the pelvic floor and psychoeducation
A multidisciplinary intervention will be carried out, consisting of an initial phase of individual physiotherapy based on specific active muscle training of the pelvic floor (EMSP).
This will be followed by a group-based multi-component physical exercise program with instructions on pelvic floor contraction during the exercises, and psychoeducation sessions to help cope with the fear of increased likelihood of falls and urinary incontinence as a result of aging.
|
A multidisciplinary intervention will be carried out, consisting of an initial phase of individual physiotherapy based on specific active muscle training of the pelvic floor (EMSP).
This will be followed by a group-based multi-component physical exercise program with instructions on pelvic floor contraction during the exercises, and psychoeducation sessions to help cope with the fear of increased likelihood of falls and urinary incontinence as a result of aging.
|
|
Active Comparator: Multi-component exercise group with verbal instructions for the pelvic floor
The same procedure as experimental group 1 (exercise + verbal instructions + psychoeducation) will be performed except for the psychoeducation sessions.
|
The same procedure as experimental group 1 ExVerbPsy will be performed except for the psychoeducation sessions.
|
|
Active Comparator: Multicomponent exercise group without verbal instructions for the pelvic floor
The same procedure as experimental group 1 (exercise + verbal instructions + psychoeducation) will be performed but without verbal instructions and psychoeducation sessions.
|
The same procedure as experimental group 1 ExVerbPsy will be performed but without verbal instructions and psychoeducation sessions.
|
|
No Intervention: Control group
They will receive information sessions on the prevention of geriatric syndromes and will be asked to maintain their normal activity level.
At the end of the interventions, this group will have the option of receiving the appropriate intervention that was not carried out in the initial process.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Pelvic floor
Time Frame: From enrollment to the end of treatment at 18 weeks
|
PERFECT Scale: Power (P): with Oxford scale 0 to 5 points Endurence (E): 0 to 10 points Repetitions (R): 0 to 10 points Fast (F): 0 to 10 points |
From enrollment to the end of treatment at 18 weeks
|
|
Pelvic floor
Time Frame: From enrollment to the end of treatment at 18 weeks.
|
Intracavitary electromyography: maximum and average contraction.
Outcome measure in microvolts.
|
From enrollment to the end of treatment at 18 weeks.
|
|
Pelvic floor
Time Frame: From enrollment to the end of treatment at 18 weeks.
|
Manometric perineometer: maximum contraction.
Outcome measure in millimeters of mercury.
|
From enrollment to the end of treatment at 18 weeks.
|
|
Abdominal muscle tone
Time Frame: From enrollment to the end of treatment at 18 weeks.
|
Abdominal ultrasound of rectus and transverse abdominis: in relaxation and activation with diaphragmatic breathing.
Outcome measure in milimeters.
|
From enrollment to the end of treatment at 18 weeks.
|
|
Dynamic balance
Time Frame: From enrollment to the end of treatment at 18 weeks
|
Timed Up and Go: the time it takes for the person to get up from a chair, walk 3 meters, turn on a cone, return to the chair and sit down.
Outcome measure in seconds.
Less than 10 seconds: low risk of falling.
Between 10 and 20 seconds: frailty (medium risk of falling).
More than 20 seconds: high risk of falling and disability.
|
From enrollment to the end of treatment at 18 weeks
|
|
Static balance
Time Frame: From enrollment to the end of treatment at 18 weeks.
|
Romberg test with feet together, semi-tandem and tandem in 10 seconds.
Static one-leg standing balance test with open and closed eyes in 30 seconds.
Outcome measure in seconds.
|
From enrollment to the end of treatment at 18 weeks.
|
|
Static balance
Time Frame: From enrollment to the end of treatment at 18 weeks.
|
Posturography with and without balance foam: anteroposterior and lateral axis oscillation, and degree of shift of the center of gravity (COP).
Outcome measure in milimeters.
|
From enrollment to the end of treatment at 18 weeks.
|
|
Static balance
Time Frame: From enrollment to the end of treatment at 18 weeks.
|
Functional reach: distance traveled in anterior displacement with arms outstretched and feet together.
Outcome measure in centimeters.
|
From enrollment to the end of treatment at 18 weeks.
|
|
Gait
Time Frame: From enrollment to the end of treatment at 18 weeks
|
Six minutes gait with Runscribe sensors on feet and four meters gait (normal and fast speed)
|
From enrollment to the end of treatment at 18 weeks
|
|
Power
Time Frame: From enrollment to the end of treatment at 18 weeks
|
Jumps (CMJ and ABK), leg extension and squad.
Outcome measure in wats.
|
From enrollment to the end of treatment at 18 weeks
|
|
Power and strenght
Time Frame: From enrollment to the end of treatment at 18 weeks
|
Five sit to stand, thirty sit to stand and arm curl.
Outcome measure in number of repetitions in 30 seconds.
|
From enrollment to the end of treatment at 18 weeks
|
|
Strenght and endurance
Time Frame: From enrollment to the end of treatment at 18 weeks
|
Isometries of leg extension, hip extension, hip abduction, hip adduction, spine extension and hand grip.
Outcome measure in newtons.
|
From enrollment to the end of treatment at 18 weeks
|
|
Health impact and quality of life
Time Frame: From enrollment to the end of treatment at 18 weeks.
|
International Consultation on Incontinence Questionnaire (ICIQ-SF): 0 to 21 points from urinary incontinence impact.
Outcome measure in units on a scale.
|
From enrollment to the end of treatment at 18 weeks.
|
|
Psychological and social well-being
Time Frame: From enrollment to the end of treatment at 18 weeks.
|
Falls efficacy scale: 16 to 64 points from least to most worry about falling.
Outcome measure in units on a scale.
|
From enrollment to the end of treatment at 18 weeks.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Quality of live
Time Frame: From enrollment to the end of treatment at 18 weeks
|
Quality of live with questionnaire Short Form (SF36): this questionnaire evalues in 36 questions the physical function, physical role, body pain, general health, vitality, social function, emotional role, and mental health.
0 to 100 points.
Outcome measure in units on a scale.
|
From enrollment to the end of treatment at 18 weeks
|
|
Psychological and social well-being
Time Frame: From enrollment to the end of treatment at 18 weeks.
|
Self-esteem questionnaire of Rosenberg: 10 points low self-esteem to 40 points high self-esteem.
Outcome measure in units on a scale.
|
From enrollment to the end of treatment at 18 weeks.
|
|
Weight
Time Frame: From enrollment to the end of treatment at 18 weeks
|
Kilograms and information on percentage of lean mass and fat mass.
|
From enrollment to the end of treatment at 18 weeks
|
|
Height
Time Frame: From enrollment to the end of treatment at 18 weeks
|
Stadiometer.
Outcome measure in centimeters
|
From enrollment to the end of treatment at 18 weeks
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: ESTHER RAMOS CASTELLANO, Escuela de Doctorado. Universidad Católica de Valencia San Vicente Mártir (Doctoral School. Catholic University of Valencia San Vicente Mártir)
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Urogenital Diseases
- Mental Disorders
- Pathologic Processes
- Male Urogenital Diseases
- Urologic Diseases
- Female Urogenital Diseases
- Female Urogenital Diseases and Pregnancy Complications
- Urination Disorders
- Lower Urinary Tract Symptoms
- Urological Manifestations
- Behavioral Symptoms
- Elimination Disorders
- Frailty
- Urinary Incontinence
- Enuresis
Other Study ID Numbers
- UCV/2022-2023/123
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Urinary Incontinence
-
Juna d.o.o.CompletedFemale Stress Urinary Incontinence | Mixed Incontinence, Urge and Stress
-
University of California, San FranciscoNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Stanford...CompletedUrinary Incontinence, Stress | Urge Incontinence | Urinary Stress Incontinence | Stress Incontinence, Urinary | Stress Incontinence | Stress Incontinence, Female | Urgency UrinaryUnited States
-
Ludwig-Maximilians - University of MunichUnknownIncontinence, Overactive Bladder, Stress Urinary IncontinenceGermany
-
San Diego Sexual MedicineRecruitingStress Urinary Incontinence | Urge IncontinenceUnited States
-
Copenhagen University Hospital at HerlevZealand University HospitalTerminatedStress Urinary Incontinence | Urge Urinary IncontinenceDenmark
-
ScitonCompletedUrinary Incontinence | Stress Urinary Incontinence | Urge IncontinenceUnited States
-
Far Eastern Memorial HospitalRecruitingWomen With Stress Urinary IncontinenceTaiwan
-
Université de SherbrookeRecruitingUrinary Incontinence | Urinary Stress Incontinence | Post-Prostatectomy Incontinence | Stress Incontinence, MaleCanada
-
University of ZurichCompletedStress Urinary Incontinence | Urge Urinary Incontinence
-
Northwestern UniversityFriends of PrenticeCompletedStress Urinary Incontinence | Mixed Urinary Incontinence | Urgency IncontinenceUnited States
Clinical Trials on Group 1: ExVerbPsy
-
Oslo University HospitalNorwegian Fund for Postgraduate Training in PhysiotherapyCompletedHealth-Related Quality of LifeNorway
-
Arkansas Children's Hospital Research InstituteTerminated
-
Ichnos Sciences SAGlenmark Pharmaceuticals S.A.CompletedModerate to Severe Atopic DermatitisUnited States, Canada, Czechia, Germany, Poland
-
Weill Medical College of Cornell UniversityTerminatedChronic Obstructive Pulmonary Disease | COPDUnited States
-
Biruni UniversityCompleted
-
Kubra GunesNot yet recruitingCardiovascular Surgery
-
Marmara UniversityCompletedStair up and Down, Amputation | Amputation,Stair up and DownTurkey
-
Shanghai General Hospital, Shanghai Jiao Tong University...UnknownRetinal Detachment | High Myopia | Macular HolesChina
-
Riphah International UniversityCompleted
-
Beijing HospitalThe First Hospital of Jilin University; Jilin University; Chinese Academy of...Not yet recruitingAsthma | Allergic Disease